Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Mechanism of the promotion of GEFS+ by the STAT3-mediated expression of interleukin-6

View through CrossRef
Abstract Genetic epilepsy with febrile seizures plus (GEFS+) is generally considered as an ion channelopathy. At present, there are few studies on inflammation associated with various types of epilepsy, and it remains unclear whether the inflammatory mechanism plays a key role in epilepsy. In order to explore the role of immune factor expression regulatory mechanism in the pathogenesis of GEFS+, the present study detected the expression level of relevant immune factors such as IL-6 in peripheral blood of GEFS + mice. The purpose of this study is to analyze and compare the effect of STAT3 expression and activation differences on GEFS + attack, and to clarify the relationship between various cytokines and GEFS + outbreak. It is expected to provide a theoretical basis for immunosuppressive therapy of GEFS + and a new way for its clinical treatment.
Springer Science and Business Media LLC
Title: Mechanism of the promotion of GEFS+ by the STAT3-mediated expression of interleukin-6
Description:
Abstract Genetic epilepsy with febrile seizures plus (GEFS+) is generally considered as an ion channelopathy.
At present, there are few studies on inflammation associated with various types of epilepsy, and it remains unclear whether the inflammatory mechanism plays a key role in epilepsy.
In order to explore the role of immune factor expression regulatory mechanism in the pathogenesis of GEFS+, the present study detected the expression level of relevant immune factors such as IL-6 in peripheral blood of GEFS + mice.
The purpose of this study is to analyze and compare the effect of STAT3 expression and activation differences on GEFS + attack, and to clarify the relationship between various cytokines and GEFS + outbreak.
It is expected to provide a theoretical basis for immunosuppressive therapy of GEFS + and a new way for its clinical treatment.

Related Results

Abstract 1404: Novel STAT3 inhibitors targeting the STAT3 dimerization
Abstract 1404: Novel STAT3 inhibitors targeting the STAT3 dimerization
Abstract Background The STAT3 pathway may drive prostate cancer (PCa) progression to metastatic castration-resistant prostate cancer (mCRPC). STAT3 may serve as a go...
Abstract 1705: 3D growth modulates the competition between STAT3 and STAT5 in breast cancer
Abstract 1705: 3D growth modulates the competition between STAT3 and STAT5 in breast cancer
Abstract Approximately 13% of women are diagnosed with invasive breast cancer. Signal Transducer and Activator of Transcription 3 (STAT3) is a transcription factor t...
Abstract 387: Pyrimethamine inhibits STAT3 transcriptional activity via dihydrofolate reductase
Abstract 387: Pyrimethamine inhibits STAT3 transcriptional activity via dihydrofolate reductase
Abstract Cancer is often characterized by aberrant gene expression patterns that alter cellular function. Such alterations are commonly caused by the inappropriat...
Panobinostat Inhibits JAK2/STAT3 Pathway in Multiple Myeloma.
Panobinostat Inhibits JAK2/STAT3 Pathway in Multiple Myeloma.
Abstract Abstract 2849 Poster Board II-825 Histone deacetylase inhibitors (HDACi) are emerging as a potential therapy for Multiple Myel...
GEFS+ Genetik Epilepsi Febril Nöbet Artı
GEFS+ Genetik Epilepsi Febril Nöbet Artı
Genetik Epilepsi Febril Nöbet artı (GEFS+), klasik febril nöbetler ile Dravet sendromu arasında değişen heterojen klinik fenotipler içeren bir ailevi epilepsi sendromudur. Aynı ail...
Intervening in the S1PR1/STAT3 Signaling Pathway Attenuates Valvular Damage Due to Rheumatic Heart Disease
Intervening in the S1PR1/STAT3 Signaling Pathway Attenuates Valvular Damage Due to Rheumatic Heart Disease
Abstract Background: Rheumatic heart disease (RHD) affects many patients every year, but its pathogenesis is still unclear. Recent studies have found that the sphingosine 1...

Back to Top